Kisspeptin plays a key role in the regulation of the reproductive system, particularly in relation to gonadotropin-releasing hormone (GnRH) secretion and reproductive behavior. Its expression in the central nervous system is closely linked to the regulation of reproductive function, stimulating GnRH neurons, which in turn modulate gonadotropin secretion, further influencing the function of the reproductive axis.
 |
 |
In addition, Kisspeptin powder plays a role in a variety of biological processes, including cell proliferation, migration and invasion. Therefore, it has a wide range of applications in reproductive medicine, oncology and other fields. It should be noted that Kisspeptin, as a peptide hormone, its purity, stability and biological activity are crucial for its application effect.
Market Applications of Kisspeptin
Kisspeptin has a wide range of applications, mainly in the biomedical field.
Reproductive function regulation
Kisspeptin plays an important role in regulating reproductive function. Studies have shown that Kisspeptin can stimulate the secretion of gonadotropin-releasing hormone (GnRH), thereby regulating the production of sex hormones, which further affects the reproductive cycle and fertility. Therefore, in the field of reproductive medicine, Kisspeptin is used in the study and treatment of problems related to reproductive function, such as infertility and sexual dysfunction.
Osteoporosis treatment
In recent years, Kisspeptin has shown potential application in the treatment of osteoporosis. It has been found that Kisspeptin can stimulate the differentiation of osteoblasts and inhibit the activity of osteoclasts, helping to increase bone density and improve bone health. This provides new ideas and methods for the treatment of osteoporosis.
Nonalcoholic fat liver disease treatment
A modified version of Kisspeptin is being used to treat non-alcoholic fatty liver disease (NAFLD), according to research from Rutgers University. The study showed that Kisspeptin protects the liver from the development of fatty liver, NASH and fibrosis, providing a new strategy for the treatment of NAFLD.
Tumor therapy
Kisspeptin has also been found to have some application in tumor therapy. As a neuropeptide, Kisspeptin can inhibit the proliferation and metastasis of tumor cells, and has inhibitory effects on a variety of tumors. Therefore, Kisspeptin may become a new target for tumor therapy.
Kisspeptin Research Development
The peptide hormone kisspeptin is a class of peptide hormones with arginine and phenylalanine at the C-terminus encoded by the Kiss-l gene, which are widely distributed throughout the body in various tissues and organs.The research on kisspeptin can be traced back to 2001, when it was discovered as a peptide hormone, encoded by the KiSS-1 gene. Kisspeptin can be hydrolyzed to produce amidated short peptides of different lengths, such as Kisspeptin-54, Kisspeptin-14, Kisspeptin-13, and Kisspeptin-10, which have arginine and phenylalanine at the C-terminal end of the peptide.Kisspeptin and its receptor are distributed in the brain and a variety of tissues and organs and have the ability to affecting the growth and metastasis of cancer cells, regulating reproductive function, and influencing endocrine secretion.
Regulating metabolism
With the deepening of research, the physiological effects of Kisspeptin have been gradually revealed. In the central nervous system and peripheral tissues and organs, Kisspeptin plays an important role in regulating the metabolism of the animal body. In recent years, it has been found that the peptide hormone kisspeptin plays an important role in the reproductive endocrine system, and is involved in individual sexual differentiation, sexual development, sexual maturation, menstrual cycle, and pregnancy by regulating the gonadal axis.
Regulating endocrine system
In addition, the Kisspeptin signaling system has been shown to be a key component in the neuroendocrine regulation of vertebrate reproductive development, and has a regulatory role in various physiological and behavioral processes, such as reproductive behavior, emotion, growth and metabolism, and even feeding behavior.
Treating osteoporosis
In recent years, the application of Kisspeptin in the treatment of osteoporosis has also attracted the attention of researchers. It has been found that Kisspeptin is able to stimulate osteoblast differentiation and inhibit osteoclasts, and therefore may have potential for the clinical treatment of osteoporosis.
Affects gonadotropins
Meanwhile, the peptide hormone kisspeptin has been shown to correlate with the development of idiopathic hypogonadotropic hypogonadism (IHH), idiopathic precocious puberty in girls, premature ovarian failure (POF), polycystic ovary syndrome (PCOS), spontaneous abortion, and trophoblastic tumors.
Overall, the history and development of Kisspeptin research is a process of continuous exploration and deepening. With the advancement of science and technology and the deeper understanding of the physiological effects of Kisspeptin, it is believed that the application of Kisspeptin in the field of biomedicine will have a broader future.
Effect of Kisspeptin on in non-pregnant women
In the blood serum of normal women of childbearing age, kisspeptin levels change regularly during the menstrual cycle. During the menstrual period, kisspeptin levels are low, reaching a first peak on day 11 of menstruation (when the dominant follicle develops to about 1.2 cm by transvaginal ultrasound), then decreasing slightly, and then rising again on day 13 of menstruation (1 d prior to the LH peak), reaching a second peak with a magnitude smaller than the first peak, and continuing to decline until ovulation. continued decline until ovulation. Correlation analysis also showed a high correlation between serum kisspeptin levels and E2 levels after day 3 of menstruation. It was hypothesized that kisspeptin interacts with E2 during the menstrual cycle of normal women of reproductive age. Meanwhile, kisspeptin promotes progesterone secretion in ovarian corpus luteum cells, possibly through the Erkl/2 schizothoracin-activated protein kinase signaling pathway. This suggests that kisspeptin plays an important role in promoting follicular development and inducing ovulation in non-pregnant women.